![Fred Feldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fred Feldman
Technik-/Wissenschafts-/F&E-Leiter bei Teva Spanish Holdco, Inc.
Aktive Positionen von Fred Feldman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Teva Spanish Holdco, Inc.
![]() Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2005 | - |
Karriereverlauf von Fred Feldman
Ehemalige bekannte Positionen von Fred Feldman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CPEX Pharmaceuticals, Inc.
![]() CPEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CPEX Pharmaceuticals, Inc. is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its validated drug delivery technology. Its technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215. The company's first product is Testim, a gel for testosterone replacement therapy, which is a formulation of its technology with testosterone. Testim is licensed to Auxilium Pharmaceuticals, Inc., which is currently marketing it in the United States, Europe and other countries. Its other product is Nasulin, which is an intranasal formulation of insulin being developed to treat hyperglycemia in patients suffering from Type 1 and Type 2 diabetes. The company was founded on September 28, 2007 and is headquartered in Exeter, NH. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2010 | 01.02.2010 |
Centeon LLC | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Aventis Behring | Corporate Officer/Principal | - | - |
Armour Pharmaceutical Co. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Fred Feldman
The University of Chicago | Undergraduate Degree |
Purdue University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Teva Spanish Holdco, Inc.
![]() Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Health Technology |
CPEX Pharmaceuticals, Inc.
![]() CPEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CPEX Pharmaceuticals, Inc. is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its validated drug delivery technology. Its technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215. The company's first product is Testim, a gel for testosterone replacement therapy, which is a formulation of its technology with testosterone. Testim is licensed to Auxilium Pharmaceuticals, Inc., which is currently marketing it in the United States, Europe and other countries. Its other product is Nasulin, which is an intranasal formulation of insulin being developed to treat hyperglycemia in patients suffering from Type 1 and Type 2 diabetes. The company was founded on September 28, 2007 and is headquartered in Exeter, NH. | Health Technology |
Aventis Behring | Health Technology |
Armour Pharmaceutical Co. | |
Centeon LLC |
- Börse
- Insiders
- Fred Feldman
- Erfahrung